发布求助
文献互助 智能选刊 最新文献

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy最新文献

筛选
英文 中文
Treatment of bacterial peritonitis. 细菌性腹膜炎的治疗。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
S Puleo, B Scilletta, T Guastella, A Licata, G Nicoletti, G Rodolico
{"title":"Treatment of bacterial peritonitis.","authors":"S Puleo,&nbsp;B Scilletta,&nbsp;T Guastella,&nbsp;A Licata,&nbsp;G Nicoletti,&nbsp;G Rodolico","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cefotetan is a semi-synthetic cephamycin antibiotic. It has combined activity against aerobes and anaerobes which makes it of particular use in the treatment and prevention of intra-abdominal infections in the surgical patient. In the course of 3 years we have evaluated the therapeutic use of cefotetan in 107 patients. Early in the evaluation of this antibiotic we used cefotetan in combination with aminoglycosides in 35 severely ill patients with intra-abdominal infections. These patients were generally in poor condition. Good results were obtained in this high risk group. A further 72 patients received cefotetan monotherapy, usually at a dose of 2 g twice daily. The majority of these patients presented with intra-abdominal infections. Overall a successful clinical response of 94% was obtained with antibiotic therapy. In conclusion the results obtained support the therapeutic use of cefotetan in the treatment of moderate to severe intra-abdominal infection.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"241-4"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14310694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan. 接受头孢西丁或头孢替坦治疗的志愿者血清对需氧菌和厌氧菌的杀菌活性。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
M Cruciani, A Navarra, L Bono, E Concia
{"title":"Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.","authors":"M Cruciani,&nbsp;A Navarra,&nbsp;L Bono,&nbsp;E Concia","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Six volunteers received intravenously a single 1 g dose of cefoxitin or cefotetan. The 2 groups were crossed after a week of washout. Five strains each of Escherichia coli, Klebsiella pneumoniae, Bacteroides fragilis and Bacteroides thetaiotaomicron susceptible to the administered drugs were tested for serum bactericidal activity (SBA). Blood samples were obtained before and 0.5, 3.0 and 12.0 hours after antibiotic injection. SBA was determined using microtitre procedures. Anaerobic bacteria were incubated in an anaerobic chamber. Cefotetan showed a very high SBA both against aerobes and anaerobes over the 12 hour sampling time. Cefoxitin reached satisfactory SBA values only 0.5 hours after administration.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"261-3"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14310696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cefotetan: antibacterial activity against Staphylococcus aureus in the presence of human serum. 头孢替坦:在人血清存在下对金黄色葡萄球菌的抗菌活性。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
J R Edwards
{"title":"Cefotetan: antibacterial activity against Staphylococcus aureus in the presence of human serum.","authors":"J R Edwards","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cefotetan is a broad spectrum cephamycin antibiotic with a long serum half-life (3-4.5 h): this is explained, in part, by serum-protein-binding (SPB) of 88%. The rate of kill of Staphylococcus aureus by cefotetan was assessed in human serum or broth containing reducing concentrations of drug simulating those seen following a 1 g intravenous dose to man. Cefotetan was bactericidal in serum despite the assumed concentration of unbound drug never reaching the minimum inhibitory concentration (MIC) for the test strain. In a separate study, ceftriaxone (SPB 96%) was more active in broth (MIC 4 mg/1) than cefotetan (MIC 16 mg/1). In 100% serum the minimum bactericidal concentration (MBC) of ceftriaxone was 64 mg/1 whilst the MBC for cefotetan was 16 mg/1.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"271-3"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14310698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy. 头孢替坦与头孢西丁加甲硝唑在阴道子宫切除术中的临床和药代动力学比较。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
K Engel, W Schmidt, H G Sonntag, F Kees
{"title":"Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy.","authors":"K Engel,&nbsp;W Schmidt,&nbsp;H G Sonntag,&nbsp;F Kees","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a randomised clinical trial, 102 women who underwent vaginal hysterectomy were given a single preoperative 2g dose of cefotetan (CTT) (52 pts) or three perioperative 2g doses of cefoxitin (CFX) plus 0.5g metronidazole (50 pts) as antibiotic prophylaxis. No statistically significant differences between the groups were detected in the clinical response (100% for both groups). The incidence of major wound infection (2% CTT and 0% CFX) were also comparable between the two treatment groups; post-operative changes in body temperature, duration of hospitalisation and post-operative urinary tract infections (16% CTT and 20% CFX) were similar. Both drugs were well tolerated. Twenty nine of the 102 patients were further investigated to determine the pharmacokinetics following a single 2g dose of CTT or CFX, in both serum and tissue. Although both antibiotics provided good concentrations during the early phase of surgery, CTT levels persisted for a longer time period. These results confirm that single dose cefotetan is equally as effective and safe as multiple dose cefoxitin plus metronidazole for prophylaxis in patients undergoing vaginal hysterectomy.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"256-60"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14185854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin. 头孢菌素治疗腹腔内感染:头孢替坦、拉他莫塞和头孢西丁的比较研究。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
S E Wilson
{"title":"Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.","authors":"S E Wilson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Two sequential randomised studies were performed to assess the efficacy of 3 different cephalosporins in the treatment of established intra-abdominal infections. In the first study 102 of 109 (94%) patients given cefotetan 2g iv every 12 hours had a satisfactory clinical response compared to 51 of 56 (91%) patients given latamoxef 2g iv every 8 hours. In the second study cefotetan 2g iv every 12 hours was compared to cefoxitin 2g iv every 6 hours with satisfactory clinical responses in 93 of 95 (98%) cefotetan-treated patients and 41 of 43 (95%) cefoxitin-treated patients. Overall response rates in the two studies were lower in patients with severe peritonitis (82%) or nosocomial infections (70%). Twelve-hourly dosing with cefotetan appears to be as effective and well tolerated in regional peritonitis as treatment with shorter-acting agents.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"213-7"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14309904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-dose prophylaxis with cefotetan in elective abdominal surgery. A controlled trial. 选择性腹部手术中单剂量头孢替坦的预防作用。对照试验。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
J A Gruwez, J Lerut, M R Christiaens, J De Roose, L Vernimmen, J Hendrickx, F Trimpeneers, H Schroé, M Deruyter, K J Williams
{"title":"Single-dose prophylaxis with cefotetan in elective abdominal surgery. A controlled trial.","authors":"J A Gruwez,&nbsp;J Lerut,&nbsp;M R Christiaens,&nbsp;J De Roose,&nbsp;L Vernimmen,&nbsp;J Hendrickx,&nbsp;F Trimpeneers,&nbsp;H Schroé,&nbsp;M Deruyter,&nbsp;K J Williams","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Single dose cefotetan was compared with either a combination of metronidazole and cefazolin given for 24 hours or 3 doses of cefuroxime as prophylaxis in elective abdominal surgery. Wound infections and infections at remote sites (UTI and RTI) were similar in all groups. In a third group prophylaxis of abdominal surgery using a single 2g dose of cefotetan was compared to 2 doses of the same drug, given 12 hours apart. There was no demonstrable advantage to giving 2 doses. The low incidence of post-operative infections seen in all groups indicates the efficacy of cefotetan in the surgical prophylaxis of elective abdominal surgery.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"218-22"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14309905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial chemoprophylaxis in colorectal surgery. 结直肠手术中的抗菌化学预防。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
F Tonelli
{"title":"Antimicrobial chemoprophylaxis in colorectal surgery.","authors":"F Tonelli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Infective complications are often seen in colorectal surgery. These even occur in cases of elective surgery and in patients where adequate bowel preparation has been performed and is due to the very high numbers of bacteria colonising the bowel. Several controlled clinical studies showed that antimicrobial prophylaxis is effective in preventing infective complications and the lack of prophylaxis is no longer justified. Antimicrobial prophylaxis can be oral (poorly absorbed antibiotics aimed to reduce the number of bacteria in the bowel) or systemic (aimed to reach a high tissue concentration when bacterial contamination occurs, in order to prevent colonisation) or a combination of the two. Which is to be preferred is still controversial. Systemic prophylaxis should have the following features: 1) use of a single agent with a broad spectrum of action, effective both on aerobes and anaerobes; 2) rapid I.V. administration, at the beginning of surgery; 3) good tissue penetration; 4) long half-life, in order to assure that the single dose will cover the whole duration of surgery; 5) good therapeutic ratio. The use of long half-life cephalosporins, particularly cefotetan, was shown to be highly beneficial. Prophylaxis can fail if contamination during surgery is severe, with a particularly high bacterial count. The degree of contamination of the operating field can be evaluated both by surgeon's judgment, and by tissue or peritoneal cavity lavage fluid sampling and culture. In case of severe contamination (bacterial number greater than 10(5) CFU/ml of fluid or mg of tissue) prolonging of antibiotic therapy for some days is justified. Otherwise, no evidence supports its prolongation beyond surgery.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"223-8"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14309906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin. 妇科和腹腔感染的治疗:头孢替坦与奈替米星加克林霉素的比较研究。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
J Poularas, H Giamarellou, G Vlachos, R Theakou, J Patoulis, N Lekakos, J Stavridis, P Sfikakis
{"title":"The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin.","authors":"J Poularas,&nbsp;H Giamarellou,&nbsp;G Vlachos,&nbsp;R Theakou,&nbsp;J Patoulis,&nbsp;N Lekakos,&nbsp;J Stavridis,&nbsp;P Sfikakis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a prospective randomised study 60 patients with gynaecological or intra-abdominal infections were given either 2g iv every 12 hours of cefotetan or a combination of netilmicin (150mg iv every 12 hours) and clindamycin (600mg iv every 8 hours). The clinical condition of nearly half the patients (26 of 60) was characterized as serious and surgical manipulation and drainage were performed in 57 of the 60 patients. The clinical response was similar in both groups with 21 of 29 patients in the cefotetan group and 29 of 33 patients in the netilmicin plus clindamycin group. Side effects were few and mild in nature with no significant differences between the two groups. This work is continuing but the results to date suggest that cefotetan monotherapy is a safe and effective alternative to a combination of netilmicin and clindamycin in the treatment of gynaecological and intra-abdominal infections.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"253-5"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14310695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylaxis in gynaecological and obstetric surgery: a comparative randomised multicentre study of single-dose cefotetan versus two doses of cefazolin. 妇科和产科手术的预防:单剂量头孢替坦与两剂量头孢唑林的比较随机多中心研究。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
P Periti, T Mazzei, E Periti
{"title":"Prophylaxis in gynaecological and obstetric surgery: a comparative randomised multicentre study of single-dose cefotetan versus two doses of cefazolin.","authors":"P Periti,&nbsp;T Mazzei,&nbsp;E Periti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Antimicrobial prophylaxis is recommended in all clean-contaminated surgery where the critical threshold of number and virulence of the contaminating organisms with respect to host resistance is reached. Obstetric and gynaecological surgery is clean-contaminated and risk of infection due to aerobic and anaerobic bacteria without prophylaxis can be quantified at 30-40% for vaginal hysterectomy, 10-35% for abdominal hysterectomy and 10-34% for caesarean section. To assess the role of two different cephalosporins as short term prophylaxis, we carried out a multicentre randomised study involving a single 2 g i.v. dose of cefotetan in comparison with two doses of cefazolin (2 g i.v. before surgery and after 8 hours). Criteria for exclusion were: exposure to antibiotics within 7 days, preoperative infection, hypersensitivity to beta-lactams. Four hundred and sixty patients entered the study, of which 229 received cefotetan and 231 cefazolin. No significant differences in mean age, obesity, preoperative weight loss, diabetes, type of disease, type of surgery (vaginal or abdominal hysterectomies and caesarean sections) and number of pregnancies and abortions existed between the two groups of patients. The total rate of infected patients undergoing hysterectomy was 8.6% (13/151) in the cefotetan group and 17.4% (29/167) in the cefazolin group (p less than 0.05). This difference was due to cases of symptomatic bacteriuria and antibiotic retreatment, while wound infections were not significantly different (2.6% and 1.8% respectively). Among patients undergoing caesarean section, 9 of 78 (11.5%) and 7 of 64 (10.9%) were infected following cefotetan and cefazolin, respectively (not significant). Cefotetan mean tissue concentrations in gynaecological organs were higher than those of cefazolin (25.5-44.8 vs. 7.4-9.5 mg/kg).(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"245-52"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14185853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report. 头孢替坦治疗胆道感染的临床和药代动力学研究:初步报告。
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy Pub Date : 1988-08-01
P Cristiano, R Lobello, M R Iovene, G De Ascentis, P Altucci, F Paradisi, L Manguso
{"title":"Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report.","authors":"P Cristiano,&nbsp;R Lobello,&nbsp;M R Iovene,&nbsp;G De Ascentis,&nbsp;P Altucci,&nbsp;F Paradisi,&nbsp;L Manguso","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Twelve hospitalised patients, affected by biliary tract infections, were treated with cefotetan at dosages ranging between 4 and 6 g daily i.v. In only 11 patients was the aetiological agent identified. Eleven patients (91.67%) completely recovered from their infections and the pathogens were eradicated; the treatment failed in only 1 patient (8.33%). Furthermore, determinations were made of cefotetan concentrations in serum, gallbladder bile, gallbladder wall and gallstones of 14 patients undergoing cholecystectomy: in 7 patients after only 1 injection i.v. of 2 g and in 7 patients after 7 injections i.v. of 2 g at intervals of 12 h. The levels recorded were several times higher than the minimum inhibitory concentrations against bacteria that are most often responsible for biliary infections. Cefotetan is a promising and effective antimicrobial agent in the therapy of biliary tract infections.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":"7 4","pages":"233-6"},"PeriodicalIF":0.0,"publicationDate":"1988-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14309908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信